Neuero Engineering, Inc.
TaiwanFDA applicant, unverified
- Devices
- 2
What Neuero Engineering, Inc. makes
Neuero Engineering, Inc. manufactures blood glucose monitoring systems, including the 3TEST GLUCOSE MONITORING SYSTEM and the 3TEST SUPREME GLUCOSE MONITORING SYSTEM, designed for continuous or intermittent diabetic management.
These devices are classified as Class II under FDA regulations and are recorded in the FDA’s 510(k) premarket notification database. The company is based in the United States.
Catalogue
3TEST Glucose Monitoring System Ref K050224
Regimes: 510(k) Registry: 510(k)3TEST Supreme Glucose Monitoring System Ref K072905
Regimes: 510(k) Registry: 510(k)
Frequently asked questions
How many devices does Neuero Engineering, Inc. have in the registry?
The registry currently lists 2 devices for Neuero Engineering, Inc.. Devices recorded under merged duplicate company entries are counted once.
Which registries list Neuero Engineering, Inc.'s devices?
Among its 2 most recently registered devices, Neuero Engineering, Inc. has devices listed in FDA 510(k) (2 devices).
What risk classes do Neuero Engineering, Inc.'s devices fall under?
Among its 2 most recently registered devices, the classes recorded for Neuero Engineering, Inc.'s devices are Class II. Each device page shows its own class and authorisation.
What are the newest devices from Neuero Engineering, Inc. in the registry?
The most recently registered devices listed for Neuero Engineering, Inc. include 3TEST GLUCOSE MONITORING SYSTEM and 3TEST SUPREME GLUCOSE MONITORING SYSTEM.